The content on this site is intended for healthcare professionals only
Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Myeloma Knowledge Exchange 2021 (MyKE Myeloma)
18 Oct 2021
Virtual
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
22 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
29 Oct 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
29 Oct 2021
High-risk SMM imaging and NDMM treatment
Dr Elena Zamagni - University of Bologna, Bologna, Italy
28 Oct 2021
Rescue after daratumumab failure
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
26 Oct 2021
MRD-driven strategies and novel immunotherapies for multiple myeloma
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
25 Oct 2021
How to approach pain management in myeloma patients
Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria
20 Oct 2021
Refractoriness and retreatment in the era of lenalidomide and mABs in the frontl...
Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
18 Oct 2021